James Paul Scopa - 07 Feb 2024 Form 4 Insider Report for Adverum Biotechnologies, Inc. (ADVM)

Role
Director
Signature
/s/ Peter Soparkar, Attorney-in-Fact
Issuer symbol
ADVM
Transactions as of
07 Feb 2024
Net transactions value
+$135,000
Form type
4
Filing time
09 Feb 2024, 17:51:56 UTC
Previous filing
27 Oct 2023
Next filing
28 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADVM Common Stock Purchase $135,000 +100,000 $1.35 100,000 07 Feb 2024 Direct F1
holding ADVM Common Stock 3,334 07 Feb 2024 By Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of the Issuer's common stock were purchased in the Issuer's private placement of common stock pursuant to a Securities Purchase Agreement, dated February 5, 2024, by and among the Issuer and the other purchaser named therein. The shares of common stock acquired were purchased at a price per share of $1.35.
F2 Shares are held directly by James Paul Scopa and Anne Eunice Kenner, as Trustees of The James P. Scopa and Anne E. Kenner Family Trust.